NCT05046938 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Gearhardt AN, Corbin WR, Brownell KD
Preliminary validation of the Yale Food Addiction Scale. Appetite. 2009 Apr;52(2):430-6. doi: 10.1016/j.appet.2008.12.003. Epub 2008 Dec 11.
Mokhtari MR, Alavi M, Pahlavanzadeh S, Weimand BM, Visentin D, Cleary M
Comparison of the effectiveness of a 12 step substance use recovery program on quality of life. Nurs Health Sci. 2020 Jun;22(2):390-397. doi: 10.1111/nhs.12668. Epub 2019 Dec 11.
Walker SN, Sechrist KR, Pender NJ
The Health-Promoting Lifestyle Profile: development and psychometric characteristics. Nurs Res. 1987 Mar-Apr;36(2):76-81.
Ware JE Jr, Sherbourne CD
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.
Ware JE Jr
SF-36 health survey update. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3130-9. Review.

The Effect of Online Group Motivational Interviewing on Eating Behaviour, Healthy Lifestyle Behaviours and Quality of Life in Nursing Students With Food Addiction: Randomized Controlled Study

Details for clinical trial NCT05046938

Clinical trial NCT05046938 - References